Alibaba has launched the first Quark AI Glasses in China, taking another step in the global race for dominance in the segment of AI-powered wearables. The starting price is 1,899 yuan, or approximately 268 dollars, highlighting the company's ambitious approach to making the product widely accessible on its home market. Deep integration with Alipay and Taobao significantly enhances its usability, covering payments and real-time price comparisons. Unlike the bulky VR headsets from Meta, which control over 80 percent of the market, Quark AI Glasses resemble regular glasses, attracting users who are reluctant to wear futuristic goggles. The glasses offer features such as live translation and shelf price recognition.
The offensive of Chinese tech giants in the field of artificial intelligence is gaining momentum. Alongside Alibaba’s recent chatbot updates, Xiaomi and Baidu have launched similar products, leaving little room for global leaders like Apple with Vision Pro or Samsung with Galaxy XR. At the same time, shares of Alibaba, Baidu, and BYD came under pressure following a report on the potential addition of these companies to the Pentagon's 1260H list, which includes entities linked to the Chinese military operating in the United States. The listing does not impose direct sanctions but signals reputational risk and may deter business partners, affecting valuations in the AI and electric vehicle sectors.
The launch of Quark AI Glasses highlights Alibaba’s strategic expansion in consumer AI, but geopolitical risks, including tensions between the United States and China, remain a significant factor pressuring Chinese tech companies.
Source: xStation5
Daily Summary: Wall Street absence limits market's activity
Precious Metals: Double Peak or Consolidation Before Growth?
Toyota - After Earnings
Stock of the Week – Adobe Inc (27.11.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
